U tijeku je upis prve generacije polaznika Sveučilišnog poslijediplomskog specijalističkog studija “Internistička onkologija” .
Stručni studij
HLZ- ESMO RSS
- FDA Approves New and Updated Indications for Temozolomide Under Project Renewal 3. listopada 2023.
- EMA Recommends Granting a Marketing Authorisation for Quizartinib 2. listopada 2023.
- Efficacy and Safety of Patritumab Deruxtecan in Patients with EGFR-mutated NSCLC that Progressed to EGFR TKI and Platinum-Based Chemotherapy 29. rujna 2023.
- A Combination of Oral Mezigdomide Plus Dexamethasone Shows Promising Efficacy in Patients with Heavily Pretreated Multiple Myeloma 28. rujna 2023.
- Trastuzumab Deruxtecan Demonstrates Durable Responses in Patients with Previously Treated HER2-mutated Metastatic NSCLC 27. rujna 2023.
